long term side effects of glp-1 drugs are already famous for weight loss, but the 2025 OHSU-led trial pushed the story further. Adults with type 1 diabetes using automated insulin delivery and weekly semaglutide were far more Are Weight Loss Injections Safe

Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a meta-analysis with the FREEDOM cardiovascular outcomes trial

Journal of Nutritional Science (2016), vol

The different pharmacokinetics of the two peptidesIpamorelin with a shorter half-life and Mod GRF 1-29 with a longer onemay contribute to both rapid and sustained activity in experimental systems

Together, lets explore how integrating nutrient-rich foods and our thoughtfully crafted supplements can enhance your journey to optimal health

Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network metaanalysis of randomised controlled trials